Covid-19 challenges US dreams for Copenhagen-based diagnostics company
In spite of Covid-19, the plans to launch in the US in 2020 is still on the table for Radiobiotics, which develops algorithms for detecting diseases on X-ray scans. The firm has entered into a new US partnership, and before the new year, it will submit an FDA application and kick off the commercialization process.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.